HIPK2 and cancer: Based on these findings, mostly obtained in pre-clinical studies, we can hypothesize that low HIPK2 mRNA or protein levels in cancer tissues compared to the adjacent normal ones can be considered a potential novel prognostic biomarkers of cancer progression, especially if correlated with increased angiogenesis.